As Estinyl, EE was formerly used for hormone replacement therapy in menopause and the treatment of female hypogonadism, loss of menstruation, dysmenorrhea, acne, prostate cancer, and breast cancer [REF].
EE has been used at very high dosages (1-2 mg/day) in the treatment of prostate cancer [REF].